Therapeutics: β-catenin (CTNNB1); CTLA-4 (CD152); programmed cell death 1 ligand 1 (PD-L1; B7-H1; CD274)

Studies in mice and patient samples suggest enhancing tumor levels of dendritic cells (DCs) could help treat CTNNB1-overexpressing melanoma. In tumor samples from melanoma patients, CTNNB1 levels nega...